About Marc-Olivier Turgeon
Form D filings for Progentos Therapeutics in 2024 list Marc-Olivier Turgeon as director.
Marc-Olivier Turgeon first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Marc-Olivier Turgeon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Marc-Olivier Turgeon works with at each company, as listed on that company's latest Form D.
Progentos Therapeutics, Inc. · Form D, May 17, 2024
AM
Aleks Radovic-Moreno
Director
DH
Dmitrij Hristodorov
Director
DJ
Dan Janney
Director
CL
Christopher Loose
CEO and director
CB
Cassidy Blundell
Director
SM
Sanjay Magavi
Executive officer